## GLP-1 Medicare and Medicaid Coverage 2026 · MomsOnGLP1
Canonical: https://momsonglp1.org/glp1-medicare-and-medicaid-coverage
Page modified: 2026-11-21T00:00:00.000Z

Medicare's $50 GLP-1 Bridge, who qualifies, the heart and sleep-apnea routes through Part D, and why Medicaid depends on your state, as of November 2026.

Real moms, real GLP-1 talk GLP-1 Coverage on Medicare and Medicaid: What I Would Check for My Mom Medicare's $50 GLP-1 Bridge, who qualifies, the heart and sleep-apnea routes through Part D, and why Medicaid depends on your state, as of November 2026. Written by Jenna Marsh — editorial research, not medical advice November 2026 On this page The short answer The Bridge, in plain words The format trap When regular Part D is the route instead What happens after 2027 Medicaid depends on the state If I were making the calls for my mom The short answer As of November 2026, Medicare still cannot cover a GLP-1 purely for weight loss through a regular Part D plan, because the law bars Part D from paying for weight-loss drugs 4 . What changed this year is a temporary side door. The Medicare GLP-1 Bridge lets eligible people get Wegovy, Foundayo or the Zepbound KwikPen for $50 a month from July 1, 2026 through December 31, 2027 1 . Medicaid is a different system and a different answer in every state. I wrote this for the daughter making calls for a parent, and for the grandmother raising kids on a fixed income, because the paperwork tends to land on one of them. The Bridge, in plain words The Bridge runs outside the person's normal drug plan, with one central processor handling the prior authorization 2 . Medicare lists who qualifies at the start of treatment 1 : A BMI of 35 or higher. A BMI of 30 or higher plus diastolic heart failure, uncontrolled high blood pressure, or stage 3a or later kidney disease. A BMI of 27 or higher plus prediabetes, a past heart attack or stroke, or peripheral artery disease with symptoms. The prescriber has to certify the drug is part of a diet and exercise program, and once approved the authorization covers refills and dose changes through 2027 unless the drug changes 1 . The person needs Part D coverage, either a standalone drug plan or a Medicare Advantage plan with drug coverage. Three details would catch my own mom. The $50 does not count toward the Part D deductible or the yearly out-of-pocket cap. Extra Help can't lower it either. And it only covers a one-month fill of 28 or 30 days 1 . The format trap For Zepbound, only the KwikPen is covered. The single-dose pens and the vials are not 1 , even though the vials are among the cheaper self-pay formats. I explained how those differ in Zepbound vials versus the KwikPen , and I would ask the prescriber to write "KwikPen" on the prescription. The pill options, Wegovy tablets and Foundayo, are covered too. When regular Part D is the route instead Here is the part people miss. The Bridge is only for people who can't get a GLP-1 through Part D already, so some people are excluded because they have a better route 2 . If the drug is prescribed for a use Part D already covers, the regular plan handles it. CMS gives two examples: Zepbound for moderate to severe obstructive sleep apnea in adults with obesity, and Wegovy to lower the risk of heart attack and stroke in adults with established heart disease and obesity or overweight 2 . People with type 2 diabetes or the qualifying form of fatty liver disease are also outside the Bridge, because Part D can cover a GLP-1 for those conditions 1 . So a grandmother with a past heart attack may be looking at her normal plan's formulary and copay rather than the $50 Bridge, and that copay could be higher or lower than $50. The sleep-apnea route works the same way; I read the evidence behind it in Zepbound and sleep apnea in women , and it's a fair question for anyone who snores and wakes exhausted. Either way, her own plan's formulary sets the price. What happens after 2027 Nobody knows yet. CMS had planned a longer program called BALANCE inside Part D, then said in 2026 that it will not launch in 2027 and extended the Bridge instead 3 . I would treat December 31, 2027 as a real end date and budget for it. Medicaid depends on the state Covering obesity drugs is optional for state Medicaid programs. As of January 2026, 13 states covered GLP-1s for obesity in fee-for-service Medicaid, down from 16 the year before 4 . States can also opt into the Medicaid side of BALANCE, with launches rolling from May 2026 into January 2027 4 . The current list lives in my GLP-1 coverage by state table, and I would check it against the state Medicaid office before assuming anything. Medicaid managed-care plans can also set their own prior-authorization forms. If I were making the calls for my mom Confirm she has Part D or a Medicare Advantage plan with drug coverage. Ask her doctor which use the prescription is for: weight, heart risk or sleep apnea. If it's weight, ask whether she meets one of the Bridge criteria and which drug and format they will prescribe. Call 1-800-MEDICARE and write down who you spoke to and when. Most private-insurance steps, like appeals and reason codes, work differently from Medicare, and I laid those out in getting a GLP-1 covered . If she lives with grandkids, I would also plan where the pens and needles are kept, the way I described in GLP-1 needles and child safety . Children open more cabinets than we expect. If no route works, I would price the Wegovy pill and other self-pay options at her real dose. Rules change quickly here, so I would recheck its website the week of the first fill. Okay, so which one? Skip the guesswork — compare providers side by side These boards sort providers by what usually matters most to a mom. Some are partners, and we may be paid if you sign up through our links. Cheapest The lowest honest monthly price I could find — teasers ignored, the all-in number ranked. Best for real life For when there's a toddler on your hip — nap-time-easy signup, no surprise bills. Fastest signup Who gets you from sign-up to a real price without dragging it out — by signup-ease score. Or go straight to the LillyDirect Foundayo review and the NovoCare Pharmacy review , or compare any two head-to-head . Frequently asked questions Does Medicare cover Wegovy or Zepbound for weight loss in 2026? Not through regular Part D, which is barred by law from covering weight-loss drugs. The temporary Medicare GLP-1 Bridge covers Wegovy, Foundayo and the Zepbound KwikPen for a $50 monthly copay for eligible people from July 1, 2026 through December 31, 2027. A prescriber must submit a prior authorization showing the person meets the clinical criteria. Who qualifies for the Medicare GLP-1 Bridge? Adults with Part D coverage who, at the start of treatment, have a BMI of 35 or higher; a BMI of 30 or higher with diastolic heart failure, uncontrolled high blood pressure or stage 3a or later kidney disease; or a BMI of 27 or higher with prediabetes, a prior heart attack or stroke, or symptomatic peripheral artery disease. People with type 2 diabetes, moderate-to-severe sleep apnea or qualifying fatty liver disease are not eligible because Part D may cover a GLP-1 for those conditions. Can Medicare cover Wegovy for heart disease or Zepbound for sleep apnea? Yes, through regular Part D rather than the Bridge. CMS says beneficiaries prescribed Wegovy to reduce cardiovascular risk with established heart disease, or Zepbound for moderate-to-severe obstructive sleep apnea with obesity, should continue to receive coverage through Part D. The plan's own formulary and cost sharing apply. Does Medicaid cover GLP-1s for weight loss? It depends on the state, because coverage is optional. As of January 2026, 13 state Medicaid programs covered GLP-1s for obesity under fee-for-service, down from 16 the year before. Check your state's Medicaid office or plan for the current rule. References Centers for Medicare & Medicaid Services ( 2026 ). Medicare GLP-1 Bridge: covered drugs, eligibility criteria, cost and how to get coverage . its website . its website Centers for Medicare & Medicaid Services ( 2026 ). Medicare GLP-1 Bridge: Expectations and Frequently Asked Questions for Part D Sponsors (HPMS memorandum, June 10, 2026) . CMS . its website Centers for Medicare & Medicaid Services ( 2026 ). Medicare GLP-1 Bridge . CMS . its website KFF (Kaiser Family Foundation) ( 2026 ). What to Know About the BALANCE Model for GLP-1s in Medicare and Medicaid and the Medicare GLP-1 Bridge . KFF . https://www.kff.org/medicare/what-to-know-about-the-balance-model-for-glp-1s-in-medicare-and-medicaid/ One mom to another, not a doctor: everything here is for learning and figuring out your options, not medical advice, a diagnosis, or a plan for your body. Pregnancy planning and breastfeeding need advice for the exact medicine and formulation. Before you start, stop, or change anything, talk it through with a clinician who actually knows your history. Continue reading Zepbound Vials vs KwikPen vs Autoinjector: The Format Question I Didn't Expect The Zepbound formats sold in November 2026 compared: how each injects, what it costs self-pay, Medicare coverage, storage for travel, and needle nerves. Read Compounded Tirzepatide in 2026: What Changed and What I Would Ask Where compounded tirzepatide stands as of November 2026: the FDA's shortage, 503A and 503B rules, safety questions to ask, and real price ranges. Read The Zepbound Savings Card and Vials: Who Actually Qualifies Who qualifies for the Zepbound savings card, LillyDirect vial and KwikPen self-pay prices by dose as of November 2026, the 45-day refill rule and what it skips. Read GLP-1 Coverage by State: What to Check With Your Plan Dated Medicaid and postpartum policy snapshots, why provider access is a separate question, and what I would confirm with the current plan. Read Foundayo (Orforglipron): What I'd Want to Know Before Starting The Foundayo label in plain English: how the daily pill is taken, the dose steps, birth control and breastfeeding rules, and what it costs as of November 2026. Read GLP-1 Needles With Kids in the House: The Setup I Would Check A parent-focused checklist for storing injection supplies, disposing of used pens and needles, and responding to an accidental needle stick. Read

Sources:
- its website
- its website
- https://www.kff.org/medicare/what-to-know-about-the-balance-model-for-glp-1s-in-medicare-and-medicaid/
- its website
